Jeff Chen
Papers
3
Total Citations
636
H-Index
3
About
Dr. Jeff Chen is a leading clinical researcher in head and neck oncology, with a focused expertise in the treatment of oropharyngeal squamous cell carcinoma (OPSCC), particularly in the context of HPV-related disease. His most significant contribution is his leadership of the landmark ORATOR clinical trial program. The phase II ORATOR trial, published in 2019 and cited over 458 times, was a pioneering randomized study that directly compared primary radiotherapy (RT) against transoral robotic surgery (TORS) with neck dissection for early-stage OPSCC. This work provided crucial, high-level evidence on the comparative efficacy and toxicity profiles of these two curative-intent modalities, directly informing clinical decision-making for patients and clinicians. Dr. Chen’s impact is further underscored by the recent 2024 publication of the trial’s final five-year results, which solidified the study’s conclusions. Through the ORATOR series, Dr. Chen has fundamentally shaped the evidence base for organ-preserving strategies in oropharyngeal cancer, establishing a benchmark for future comparative effectiveness research in the field.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3